Cargando…
The use of radiosensitizing agents in the therapy of glioblastoma multiforme—a comprehensive review
BACKGROUND: Glioblastoma is the most common malignant brain tumor in human adults. Despite several improvements in resective as well as adjuvant therapy over the last decades, its overall prognosis remains poor. As a means of improving patient outcome, the possibility of enhancing radiation response...
Autores principales: | Pepper, Niklas Benedikt, Stummer, Walter, Eich, Hans Theodor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165247/ https://www.ncbi.nlm.nih.gov/pubmed/35503461 http://dx.doi.org/10.1007/s00066-022-01942-1 |
Ejemplares similares
-
Dodecafluoropentane Emulsion as a Radiosensitizer in Glioblastoma Multiforme
por: Lickliter, Jason D., et al.
Publicado: (2023) -
Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme
por: Choi, Jinyeong, et al.
Publicado: (2020) -
Using Light for Therapy of Glioblastoma Multiforme (GBM)
por: Vasilev, Alex, et al.
Publicado: (2020) -
Lomeguatrib Increases the Radiosensitivity of MGMT Unmethylated Human Glioblastoma Multiforme Cell Lines
por: Kirstein, Anna, et al.
Publicado: (2021) -
Glioblastoma Multiforme Therapy and Mechanisms of Resistance
por: Ramirez, Yulian P., et al.
Publicado: (2013)